Schedule 13G ownership disclosure
Intec Pharma Ltd.
Security class unavailable · CUSIP: M53644106
Event date: 2017-04-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.3900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001178913-17-001128
- Form type
- SC 13G
- Filer
- Intec Pharma Ltd.
- CIK
- CIK 1638381
- Filed
- Apr 19, 2017
- Reporting period
- Apr 09, 2017
- Description
- Schedule 13G beneficial ownership